Stress and drug resistance in cancer

Renee Flaherty; Marta Falcinelli; Melanie Flint

doi:10.20517/cdr.2019.016

Stress and drug resistance in cancer

Renee Flaherty, Marta Falcinelli, Melanie Flint

Centre for Lifelong Health

Research output: Contribution to journal › Article › peer-review

Abstract

Patients diagnosed with cancer often undergo considerable psychological distress, and the induction of the psychological stress response has been linked with a poor response to chemotherapy. The psychological stress response is mediated by fluctuations of the hormones glucocorticoids (GC’s) and catecholamines. Binding to their respective receptors, GC’s and the catecholamines adrenaline/noradrenaline are responsible for signalling a wide range of processes involved in cell survival, cell cycle and immune function. Synthetic GC’s are also often prescribed as co-medication alongside chemotherapy, and increasing evidence suggests that GC’s may induce chemoresistance in multiple cancer types. In this review, we bring together evidence linking psychological stress hormone signalling with resistance to chemo- and immune therapies, as well as mechanistic evidence regarding the effects of exogenous stress hormones on the efficacy of chemotherapies.

Original language	English
Journal	Cancer Drug resistance
Volume	2
DOIs	https://doi.org/10.20517/cdr.2019.016
Publication status	Published - 27 Jun 2019

Bibliographical note

© The Author(s) 2019. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Keywords

Cancer
Drug resistance

Access to Document

10.20517/cdr.2019.016Licence: CC BY

Stress and drug resistance in cancerFinal published version, 978 KBLicence: CC BY

Melanie Flint
- M.Flintbrighton.acuk
- School of Applied Sciences - Professor of Stress and Cancer Research
- Centre for Lifelong Health
Person: Academic

Cite this

@article{700469adf41f431b9aed459241afed12,

title = "Stress and drug resistance in cancer",

abstract = "Patients diagnosed with cancer often undergo considerable psychological distress, and the induction of the psychological stress response has been linked with a poor response to chemotherapy. The psychological stress response is mediated by fluctuations of the hormones glucocorticoids (GC{\textquoteright}s) and catecholamines. Binding to their respective receptors, GC{\textquoteright}s and the catecholamines adrenaline/noradrenaline are responsible for signalling a wide range of processes involved in cell survival, cell cycle and immune function. Synthetic GC{\textquoteright}s are also often prescribed as co-medication alongside chemotherapy, and increasing evidence suggests that GC{\textquoteright}s may induce chemoresistance in multiple cancer types. In this review, we bring together evidence linking psychological stress hormone signalling with resistance to chemo- and immune therapies, as well as mechanistic evidence regarding the effects of exogenous stress hormones on the efficacy of chemotherapies. ",

keywords = "Cancer, Drug resistance",

author = "Renee Flaherty and Marta Falcinelli and Melanie Flint",

note = "{\textcopyright} The Author(s) 2019. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",

year = "2019",

month = jun,

day = "27",

doi = "10.20517/cdr.2019.016",

language = "English",

volume = "2",

journal = "Cancer Drug resistance",

}

TY - JOUR

T1 - Stress and drug resistance in cancer

AU - Flaherty, Renee

AU - Falcinelli, Marta

AU - Flint, Melanie

N1 - © The Author(s) 2019. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

PY - 2019/6/27

Y1 - 2019/6/27

N2 - Patients diagnosed with cancer often undergo considerable psychological distress, and the induction of the psychological stress response has been linked with a poor response to chemotherapy. The psychological stress response is mediated by fluctuations of the hormones glucocorticoids (GC’s) and catecholamines. Binding to their respective receptors, GC’s and the catecholamines adrenaline/noradrenaline are responsible for signalling a wide range of processes involved in cell survival, cell cycle and immune function. Synthetic GC’s are also often prescribed as co-medication alongside chemotherapy, and increasing evidence suggests that GC’s may induce chemoresistance in multiple cancer types. In this review, we bring together evidence linking psychological stress hormone signalling with resistance to chemo- and immune therapies, as well as mechanistic evidence regarding the effects of exogenous stress hormones on the efficacy of chemotherapies.

AB - Patients diagnosed with cancer often undergo considerable psychological distress, and the induction of the psychological stress response has been linked with a poor response to chemotherapy. The psychological stress response is mediated by fluctuations of the hormones glucocorticoids (GC’s) and catecholamines. Binding to their respective receptors, GC’s and the catecholamines adrenaline/noradrenaline are responsible for signalling a wide range of processes involved in cell survival, cell cycle and immune function. Synthetic GC’s are also often prescribed as co-medication alongside chemotherapy, and increasing evidence suggests that GC’s may induce chemoresistance in multiple cancer types. In this review, we bring together evidence linking psychological stress hormone signalling with resistance to chemo- and immune therapies, as well as mechanistic evidence regarding the effects of exogenous stress hormones on the efficacy of chemotherapies.

KW - Cancer

KW - Drug resistance

U2 - 10.20517/cdr.2019.016

DO - 10.20517/cdr.2019.016

M3 - Article

VL - 2

JO - Cancer Drug resistance

JF - Cancer Drug resistance

ER -

Stress and drug resistance in cancer

Abstract

Bibliographical note

Keywords

Access to Document

Fingerprint

Profiles

Melanie Flint

Cite this